SNDX

Syndax Pharmaceuticals Stock Analysis

AI Rating

Neutral
  • Quality0/10
  • Growth↓ 4/10
  • Value↑ 5/10
Syndax Pharmaceuticals sales and earnings growth
SNDX Growth
Neutral
  • Revenue Y/Y↑ 385.01%
  • EPS Y/Y↑ 27.53%
  • FCF Y/Y↓ 2.85%
Syndax Pharmaceuticals gross and profit margin trends
SNDX Profitability
Neutral
  • Gross margin ↑ 96.00%
  • EPS margin↓ -111.90%
  • ROIC 5Y↓ -60.02%
Syndax Pharmaceuticals net debt vs free cash flow
SNDX Risk
Poor
  • Debt / Equity↑ 8.3
  • Debt / FCF↓ 0.8
  • Interest coverage↓ -5.5

Syndax Pharmaceuticals stock volatility is in-line with the overall market. We give it a Poor risk rating.

↗ More Biotechnology stocks